Logo image of SNWV

SANUWAVE HEALTH INC (SNWV) Stock Fundamental Analysis

NASDAQ:SNWV - Nasdaq - US80303D3052 - Common Stock - Currency: USD

29.18  +1.56 (+5.65%)

Fundamental Rating

2

Overall SNWV gets a fundamental rating of 2 out of 10. We evaluated SNWV against 188 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of SNWV have multiple concerns. SNWV is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year SNWV has reported negative net income.
SNWV had a positive operating cash flow in the past year.
SNWV had negative earnings in each of the past 5 years.
SNWV had a negative operating cash flow in each of the past 5 years.
SNWV Yearly Net Income VS EBIT VS OCF VS FCFSNWV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M

1.2 Ratios

SNWV has a better Return On Assets (-1.78%) than 71.81% of its industry peers.
Industry RankSector Rank
ROA -1.78%
ROE N/A
ROIC N/A
ROA(3y)-104.44%
ROA(5y)-151.21%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SNWV Yearly ROA, ROE, ROICSNWV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500

1.3 Margins

SNWV has a Operating Margin of 13.43%. This is amongst the best in the industry. SNWV outperforms 81.91% of its industry peers.
With an excellent Gross Margin value of 72.84%, SNWV belongs to the best of the industry, outperforming 84.57% of the companies in the same industry.
SNWV's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.43%
PM (TTM) N/A
GM 72.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.44%
GM growth 5Y2.41%
SNWV Yearly Profit, Operating, Gross MarginsSNWV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600 -800 -1K

More info and screens

2

2. Health

2.1 Basic Checks

SNWV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SNWV has been increased compared to 1 year ago.
SNWV has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, SNWV has an improved debt to assets ratio.
SNWV Yearly Shares OutstandingSNWV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M
SNWV Yearly Total Debt VS Total AssetsSNWV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -15.57, we must say that SNWV is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -15.57, SNWV is doing worse than 85.11% of the companies in the same industry.
SNWV has a debt to FCF ratio of 94.71. This is a negative value and a sign of low solvency as SNWV would need 94.71 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 94.71, SNWV is doing good in the industry, outperforming 68.09% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 94.71
Altman-Z -15.57
ROIC/WACCN/A
WACC8.49%
SNWV Yearly LT Debt VS Equity VS FCFSNWV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10M -20M -30M -40M

2.3 Liquidity

SNWV has a Current Ratio of 0.12. This is a bad value and indicates that SNWV is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.12, SNWV is not doing good in the industry: 96.81% of the companies in the same industry are doing better.
A Quick Ratio of 0.08 indicates that SNWV may have some problems paying its short term obligations.
SNWV has a Quick ratio of 0.08. This is amonst the worse of the industry: SNWV underperforms 96.81% of its industry peers.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.08
SNWV Yearly Current Assets VS Current LiabilitesSNWV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 34.19% over the past year.
SNWV shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -44.40%.
SNWV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.95% yearly.
EPS 1Y (TTM)34.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-44.4%
Revenue growth 3Y-9.24%
Revenue growth 5Y3.95%
Sales Q2Q%47.7%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-2%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year228.83%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SNWV Yearly Revenue VS EstimatesSNWV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
SNWV Yearly EPS VS EstimatesSNWV Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 -10 -20 -30

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SNWV. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SNWV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SNWV Price Earnings VS Forward Price EarningsSNWV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SNWV is valued a bit cheaper than 67.55% of the companies in the same industry.
SNWV's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. SNWV is cheaper than 68.62% of the companies in the same industry.
Industry RankSector Rank
P/FCF 726.11
EV/EBITDA 48.97
SNWV Per share dataSNWV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SNWV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SANUWAVE HEALTH INC

NASDAQ:SNWV (5/29/2025, 12:25:14 PM)

29.18

+1.56 (+5.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-08 2025-04-08
Earnings (Next)08-11 2025-08-11
Inst Owners27.65%
Inst Owner Change187576%
Ins Owners2.56%
Ins Owner Change0%
Market Cap249.78M
Analysts82.86
Price TargetN/A
Short Float %0.17%
Short Ratio0.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.52
P/FCF 726.11
P/OCF 582.24
P/B N/A
P/tB N/A
EV/EBITDA 48.97
EPS(TTM)-18.75
EYN/A
EPS(NY)-19.12
Fwd EYN/A
FCF(TTM)0.04
FCFY0.14%
OCF(TTM)0.05
OCFY0.17%
SpS3.42
BVpS-7.04
TBVpS-8.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.78%
ROE N/A
ROCE -6.59%
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 13.43%
PM (TTM) N/A
GM 72.84%
FCFM 1.17%
ROA(3y)-104.44%
ROA(5y)-151.21%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.44%
GM growth 5Y2.41%
F-Score7
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 94.71
Debt/EBITDA 5.07
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 0.94
Cash Conversion 8.72%
Profit Quality N/A
Current Ratio 0.12
Quick Ratio 0.08
Altman-Z -15.57
F-Score7
WACC8.49%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-2%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-44.4%
Revenue growth 3Y-9.24%
Revenue growth 5Y3.95%
Sales Q2Q%47.7%
Revenue Next Year228.83%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y185.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y102.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y103.28%
OCF growth 3YN/A
OCF growth 5YN/A